The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Angiogenesis Gene Therapy: Phase I Assessment of Direct Intramyocardial Administration of an Adenovirus Vector Expressing VEGF121 cDNA to Individuals With Clinically Significant Severe Coronary Artery Disease
Open accessAbstract
Background —Therapeutic angiogenesis, a new experimental strategy for the treatment of vascular insufficiency, uses the administration of mediators known to induce vascular development in embryogenesis to induce neovascularization of ischemic adult tissues. This report summarizes a phase I clinical experience with a gene-therapy strategy that used an E1 − E3 − adenovirus (Ad) gene-transfer vector expressing human vascular endothelial growth factor (VEGF) 121 cDNA (Ad GV VEGF121.10) to induce therapeutic angiogenesis in the myocardium of individuals with clinically significant coronary artery disease. Methods and Results —Ad GV VEGF121.10 was administered to 21 individuals by direct myocardial injection into an area of reversible ischemia either as an adjunct to conventional coronary artery bypass grafting (group A, n=15) or as sole therapy via a minithoracotomy (group B, n=6). There was no evidence of systemic or cardiac-related adverse events related to vector administration. In both groups, coronary angiography and stress sestamibi scan assessment of wall motion 30 days after therapy suggested improvement in the area of vector administration. All patients reported improvement in angina class after therapy. In group B, in which gene transfer was the only therapy, treadmill exercise assessment suggested improvement in most individuals. Conclusions —The data are consistent with the concept that direct myocardial administration of Ad GV VEGF121.10 to individuals with clinically significant coronary artery disease appears to be well tolerated, and initiation of phase II evaluation of this therapy is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Letter: Grading of angina pectoris.
Campeau, L. (1976) · Circulation · doi:10.1161/circ.54.3.947585 · Cited by 1,601
Signaling Vascular Morphogenesis and Maintenance
Hanahan, D. (1997) · Science · doi:10.1126/science.277.5322.48 · Cited by 1,190
Folkman, J., & Haudenschild, C. (1980) · Nature · doi:10.1038/288551a0 · Cited by 1,037
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90213-v · Cited by 931
Self-citationCrystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 826
Self-citationEvaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
Mittereder, N., March, K. L., & Trapnell, B. C. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7498-7509.1996 · Cited by 777
The vascular endothelial growth factor family of polypeptides
Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., & Leung, D. W. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470305 · Cited by 641
Banks, R., Forbes, M., Kinsey, S., Stanley, A., Ingham, E., Walters, C., & Selby, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.158 · Cited by 599
Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent
Thomas, K. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.603 · Cited by 556
Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 491
Self-citationAdenoviruses as Gene-Delivery Vehicles
Wilson, J. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341809 · Cited by 476
Banai, S., Shweiki, D., Pinson, A., Chandra, M., Lazarovici, G., & Keshet, E. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.8.1176 · Cited by 428
Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy
Gao, G. P., Yang, Y., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8934-8943.1996 · Cited by 370
Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., & Blau, H. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80154-9 · Cited by 363
VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis
Li, J., Brown, L. F., Hibberd, M. G., Grossman, J. D., Morgan, J. P., & Simons, M. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.5.h1803 · Cited by 340
Mack, C. A., Patel, S. R., Schwarz, E. A., Zanzonico, P., Hahn, R. T., Ilercil, A., Devereux, R. B., Goldsmith, S. J., Christian, T. F., Sanborn, T. A., et al. (1998) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70455-6 · Cited by 305
Self-citationMack, C. A., Song, W.-R., Carpenter, H., Wickham, T. J., Kovesdi, I., Harvey, B.-G., Magovern, C. J., Isom, O. W., Rosengart, T., Falck-Pedersen, E., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-99 · Cited by 192
Self-citationHarvey, B., Hackett, N. R., El-Sawy, T., Rosengart, T. K., Hirschowitz, E. A., Lieberman, M. D., LESSER, M. L., & Crystal, R. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6729-6742.1999 · Cited by 153
Self-citationMühlhauser, J., Merrill, M. J., Пили, Р., Maeda, H., Bacic, M., Bewig, B., Passaniti, A., Edwards, N. A., Crystal, R. G., & Capogrossi, M. C. (1995) · Circulation Research · doi:10.1161/01.res.77.6.1077 · Cited by 151
Self-citationMack, C. A., Magovern, C. J., Budenbender, K. T., Patel, S. R., Schwarz, E. A., ZANZONICO, P. B., Ferris, B., Sanborn, T. A., Isom, O. W., Crystal, R. G., et al. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70236-8 · Cited by 131
Self-citationOkin, P. M., & Kligfield, P. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00085-i · Cited by 101
Self-citationKligfield, P., Hochreiter, C. A., Kramer, H. M., Devereux, R. B., Niles, N. W., Kramer-Fox, R., & BORER, J. S. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90970-1 · Cited by 97
Self-citationTherapeutic Angiogenesis: Protein and Gene Therapy Delivery Strategies
Rosengart, T. K., Patel, S. R., & Crystal, R. G. (1999) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748739900600106 · Cited by 53
Self-citation
Cited by
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
The Role of Vascular Endothelial Growth Factor in Wound Healing
Bao, P., Kodra, A., Tomic-Canic, M., Golinko, M. S., Ehrlich, H. P., & Brem, H. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.04.023 · Cited by 1,211
The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis
Henry, T. D., Annex, B. H., McKendall, G. R., Azrin, M. A., Lopez, J. J., Giordano, F. J., Shah, P. K., Willerson, J. T., Benza, R. L., Berman, D. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000061911.47710.8a · Cited by 1,025
Metadata
- Authors
- Rosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., Hahn, R. T., Devereux, R. B., Post, M. R., Hackett, N. R., Foster, T., Grasso, T. M., Lesser, M. L., Isom, O. W., & Crystal, R. G.
- Venue
- Circulation
- Published
- 1999-08-03
- Volume
- 100
- Issue
- 5
- Pages
- 468-474
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2002111141
- Cited by
- 656
- References
- 24
- FWCI
- 34.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.